About Themasap Khan
Form D filings for Curve Biosciences in 2024 list Themasap Khan as director.
Themasap Khan first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Themasap Khan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Themasap Khan works with at each company, as listed on that company's latest Form D.
Curve Biosciences, Inc. · Form D, May 13, 2024
CO
Chuba Oyolu
Executive officer
NH
Nathan Hunkapiller
Executive officer
SW
Shan Xiang Wang
Executive officer and director
RP
Ritish Patnaik
Chief Executive Officer and director